High incidence of autoimmune alterations in chronic myeloid leukemia patients treated with interferon-α

American Journal of Hematology

Volumn 72, Issue 3, 2003, Pages 170-176

  Steegmann, J L ^a   Requena, M J ^a   Martin Regueira P ^a   De la Camara R ^a   Casado, F ^a   Rodriguez Salvanes F ^a   Fernandez Ranada J M ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Autoimmunity; Chronic myeloid leukemia; Interferon

Indexed keywords

ALPHA INTERFERON; ANTINUCLEAR ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; IMMUNOGLOBULIN; MITOCHONDRION ANTIBODY; RHEUMATOID FACTOR; SMOOTH MUSCLE ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; BONE MARROW TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; HUMAN; HYPOTHYROIDISM; IMMUNOFLUORESCENCE; IMMUNOMODULATION; INCIDENCE; LONG TERM CARE; MALE; PATHOGENESIS; PATIENT SELECTION; PRIORITY JOURNAL; SEX RATIO; STATISTICAL ANALYSIS; TIME SERIES ANALYSIS; TREATMENT PLANNING;

ADOLESCENT; ADULT; AUTOANTIBODIES; AUTOIMMUNE DISEASES; COOMBS' TEST; FEMALE; HUMANS; INTERFERON-ALPHA; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MALE; MIDDLE AGED; SEX CHARACTERISTICS; THYROIDITIS, AUTOIMMUNE; TIME FACTORS;

EID: 0037373177     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10282     Document Type: Article

References (28)

1. Italian Cooperative Study Group on Chronic Myeloid Leukemia. Interferon alpha-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. New Engl J Med 1994;330: 820.
2. Kantarjian HM, Smith TL, O'Brien S, Beran M, Pierce S, Talpaz M, Leukemia Service. Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-α therapy. Ann Intern Med 1995;122:254.
3. 2a and CML. Haematologica 1999;84:978.
4. Lisker-Melman M, Di Bisceglie AM, Usala SJ, Weintraub B, Murray LM, Hoofnagle JH. Development of thyroid disease during therapy of chronic viral hepatitis with interferon alpha. Gastroenterology 1992; 102:2155.
5. Sacchi S, Kantarjian H, O'Brien S, Cohen PR, Pierce S, Talpaz M. Immune-mediated and unusual complications during IFN alpha therapy in chronic myelogenous leukemia. J Clin Oncol 1995;13:2401.
6. Fattovich G, Betterle C, Brollo L, Pedini B, Giustina G, Realdi G, Alberti A, Ruol A. Autoantibodies during alpha-interferon therapy for chronic hepatitis B. J Med Virol 1991;34:132.
7. Papo T, Oksenhendler E, Izembart M, Leger A, Clauvel JP. Antithyroid hormone antibodies induced by interferon-α. J Clin Endocrinol Metab 1992;75:1484.
8. Gisslinger H, Gilly B, Woloszczuk W, Mayr WR, Havelec L, Linkesch W, Weissel M. Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-α. Clin Exp Immunol 1992;90:363.
9. Fritzler MJ. Drugs recently associated with lupus syndromes. Lupus 1994;3:455.
10. Yavorkovsky LL, Carrum G, Bruce S, McCarthy PL Jr. Cutaneous sarcoidosis in a patient with Philadelphia-positive chronic myelogenous leukemia treated with interferon-α. Am J Hematol 1998;58:80.
11. Quesada JR, Gutterman JU. Psoriasis and α-interferon. Lancet 1986;1:1466.
12. Colon KC, Urba WJ, Smith JW, Steis RG, Longo DL, Clark JW. Exacerbation of symptoms of autoimmune disease in patients receiving α-interferon therapy. Cancer 1990;65:2237.
13. Herberman RB. Effect of α-interferons on immune function. Semin Oncol 1997;24:S9-78.
14. Imura H, Fukala J, Mori T. Cytokines and endocrine function: an interaction between the immune and neuroendocrine systems. Clin Endocrinol 1991;35:107.
15. Talpaz M, Kantarjian HM, McCredie K, Trujillo JM, Keating MJ, Gutterman JU. Hematologic remission and cytogenetic improvement induced by recombinant human interferon α A in chronic myelogenous leukemia. N Engl J Med 1986;314:1065.
16. Kantarjian HM, Keating MJ, Smith TL, Talpaz M, McCredie KB. Proposal for a simple synthesis prognostic staging system in chronic myelogenous leukemia. Am J Med 1990;88:1.
17. Steegmann JL, Requena MJ, García-Buey M, Granados E, Romero R, Fernández-Rañada JM, Moreno R. Severe autoimmune hepatitis in a chronic myeloid leukemia patient treated with interferon α and with complete genetic response. Am J Hematol 1998;59:95.
18. Arbaje YM, Beltran G. Chronic myelogenous leukemia complicated by autoimmune hemolytic anemia. Am J Med 1990;88:197.
19. Härfast B, Huddestone JR, Casali P, Merigan TC, Oldstone B. Interferon acts directly on human B Lymphocytes to modulate immuno-globulin synthesis. J Immunol 1981;127:2146.
20. Fridman WH, Gresser I, Bandu MT, Aguet M, Neauport-Sautes C. Interferon enhances the expression of FcY receptors. J Immunol 1980; 124:2436.
21. Talpaz M, Estrov Z, Kantarjian H, Ku S, Foteh A, Kurzrock R. Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. Analysis by polymerase chain reaction of individual colonies. J Clin Invest 1994;94:1383.
22. Deng M, Daley GQ. Expression of interferon consensus sequence binding protein induces potent immunity against BCR/ABL-induced leukemia. Blood 2001;97:3491.
23. Ronnblom LE, Alm GV, Öberg KE. Autoimmunity after α-interferon therapy for malignant carcinoid tumors. Ann Intern Med 1991;115: 178.
24. Sinha AA, Lopez MT, McDevitt HO. Autoimmune diseases: the failure of self-tolerance. Science 1990;248:1380.
25. Hawkins BR, Dawkins RL, Burger HG, Mackay IR, Cheah PS, Whittingham S, Patel Y, Welborn TA. Diagnostic significance of thyroid microsomal antibodies in randomly selected population. Lancet 1980;2:1057.
26. Steegmann JL, Pinilla I, Requena MJ, de la Cámara R, Granados E, Fernández Villalta MJ, Fernández-Rañada JM. The direct antiglobulin test is frequently positive in chronic myeloid leukemia patients treated with interferon-α. Transfusion 1997;37:446.
27. Andriani A, Bibas M, Callea V, De Renzo A, Chiurazzi F, Marceno R, Musto P, Rotoli B. Autoimmune hemolytic anemia during α interferon treatment in nine patients with hematological diseases. Haematologica 1996;81:258.
28. Bell TM, Bansal AS, Shorthouse C, Sandford N, Powell EE. Low-titre auto-antibodies predict autoimmune disease during interferon-α treatment of chronic hepatitis C. J Gastroenterol Hepatol 1999;14:419.